STATE-OF-THE-ART PAPER
Role of Diminished Renal Function in Cardiovascular Mortality
Marker or Pathogenetic Factor?
Robert W. Schrier, MD*
University of Colorado School of Medicine, Division of Renal Diseases and Hypertension, Denver, Colorado.
Manuscript received March 31, 2005;
revised manuscript received July 7, 2005,
accepted July 18, 2005.
* Reprint requests and correspondence: Dr. Robert W. Schrier, University of Colorado School of Medicine, Division of Renal Diseases and Hypertension, 4200 East Ninth Avenue B-173, Denver, Colorado 80262. (Email: robert.schrier{at}uchsc.edu).
The interactions between the heart and the kidney recently have been the focus of intense interest because of epidemiological evidence indicating that even mild deterioration of renal function is an important risk factor for poor outcome in patients with congestive heart failure, myocardial infarction, and cardiovascular surgery. Kidney function deterioration may be a consequence of cardiac and baroreceptor dysfunction or may be primarily caused by intrinsic kidney disease. This review provides a comprehensive analysis of the role of the kidney not only as a marker but also as a pathogenic factor in cardiorenal syndromes, whether primary heart or primary kidney disease or both are the initiators of the subsequent pathophysiological events.
|
Abbreviations and Acronyms
| | BNP = brain natriuretic peptide | | CHF = congestive heart failure | | ECF = extracellular fluid | | GFR = glomerular filtration rate | | HF = heart failure | | LV = left ventricular |
|
This article has been cited by other articles:

|
 |

|
 |
 
M. Albaghdadi, M. Gheorghiade, and B. Pitt
Mineralocorticoid receptor antagonism: therapeutic potential in acute heart failure syndromes
Eur. Heart J.,
November 1, 2011;
32(21):
2626 - 2633.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
ACT Investigators
Acetylcysteine for Prevention of Renal Outcomes in Patients Undergoing Coronary and Peripheral Vascular Angiography: Main Results From the Randomized Acetylcysteine for Contrast-Induced Nephropathy Trial (ACT)
Circulation,
September 13, 2011;
124(11):
1250 - 1259.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Lindenfeld and R. W. Schrier
Blood Urea Nitrogen: A Marker for Adverse Effects of Loop Diuretics?
J. Am. Coll. Cardiol.,
July 19, 2011;
58(4):
383 - 385.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Klein
Omnes Viae Romam Ducunt: Asymptomatic Cardiac and Noncardiac Organ System Dysfunction Leads to Heart Failure
Circulation,
July 5, 2011;
124(1):
4 - 6.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. T. McGuane, J. E. Debrah, L. Sautina, Y. P. R. Jarajapu, J. Novak, J. P. Rubin, M. B. Grant, M. Segal, and K. P. Conrad
Relaxin Induces Rapid Dilation of Rodent Small Renal and Human Subcutaneous Arteries via PI3 Kinase and Nitric Oxide
Endocrinology,
July 1, 2011;
152(7):
2786 - 2796.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-Y. Lee, D.-W. Park, Y.-H. Kim, S.-C. Yun, W.-J. Kim, S.-J. Kang, S.-W. Lee, C.-W. Lee, S.-W. Park, and S.-J. Park
Incidence, Predictors, Treatment, and Long-Term Prognosis of Patients With Restenosis After Drug-Eluting Stent Implantation for Unprotected Left Main Coronary Artery Disease
J. Am. Coll. Cardiol.,
March 22, 2011;
57(12):
1349 - 1358.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Paoletti, D. Bellino, A. M. Gallina, M. Amidone, P. Cassottana, and G. Cannella
Is left ventricular hypertrophy a powerful predictor of progression to dialysis in chronic kidney disease?
Nephrol. Dial. Transplant.,
February 1, 2011;
26(2):
670 - 677.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. K. Wali, M. Iyengar, G. J. Beck, D. M. Chartyan, M. Chonchol, M. A. Lukas, C. Cooper, J. Himmelfarb, M. R. Weir, T. Berl, et al.
Efficacy and Safety of Carvedilol in Treatment of Heart Failure with Chronic Kidney Disease: A Meta-Analysis of Randomized Trials
Circ Heart Fail,
January 1, 2011;
4(1):
18 - 26.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. A. Jackson and K. A. Eagle
Smoking Interventions: The Beginning of the End or the End of the Beginning?
J. Am. Coll. Cardiol.,
December 14, 2010;
56(25):
2113 - 2114.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Damman, A. A. Voors, H. L. Hillege, G. Navis, P. Lechat, D. J. van Veldhuisen, H. J. Dargie, and for the CIBIS-2 Investigators and Committees
Congestion in chronic systolic heart failure is related to renal dysfunction and increased mortality
Eur J Heart Fail,
September 1, 2010;
12(9):
974 - 982.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Garg and P. W. Serruys
Coronary Stents: Current Status
J. Am. Coll. Cardiol.,
August 31, 2010;
56(10_Suppl_S):
S1 - S42.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. J. MacFadyen, M. J. Ng Kam Chuen, and R. C. Davis
Loop diuretic therapy in left ventricular systolic dysfunction: has familiarity bred contempt for a critical but potentially nephrotoxic cardio renal therapy?
Eur J Heart Fail,
July 1, 2010;
12(7):
649 - 652.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Chrysohoou, D. B. Panagiotakos, C. Pitsavos, J. Skoumas, M. Toutouza, I. Papaioannou, and C. Stefanadis
Renal function, cardiovascular disease risk factors' prevalence and 5-year disease incidence; the role of diet, exercise, lipids and inflammation markers: the ATTICA study
QJM,
June 1, 2010;
103(6):
413 - 422.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. O. Kilickesmez, O. Abaci, B. Okcun, C. Kocas, M. Baskurt, A. Arat, M. Ersanli, and T. Gurmen
Chronic Kidney Disease as a Predictor of Coronary Lesion Morphology
Angiology,
May 1, 2010;
61(4):
344 - 349.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Gheorghiade, F. Follath, P. Ponikowski, J. H. Barsuk, J. E. A. Blair, J. G. Cleland, K. Dickstein, M. H. Drazner, G. C. Fonarow, T. Jaarsma, et al.
Assessing and grading congestion in acute heart failure: a scientific statement from the Acute Heart Failure Committee of the Heart Failure Association of the European Society of Cardiology and endorsed by the European Society of Intensive Care Medicine
Eur J Heart Fail,
May 1, 2010;
12(5):
423 - 433.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. W. Schrier
Fluid Administration in Critically Ill Patients with Acute Kidney Injury
Clin. J. Am. Soc. Nephrol.,
April 1, 2010;
5(4):
733 - 739.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. C. Wijeysundera, B. K. Nallamothu, H. M. Krumholz, J. V. Tu, and D. T. Ko
Meta-analysis: Effects of Percutaneous Coronary Intervention Versus Medical Therapy on Angina Relief
Ann Intern Med,
March 16, 2010;
152(6):
370 - 379.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Poggio, H. O. Grancelli, and S. G. Miriuka
Understanding the risk of hyperkalaemia in heart failure: role of aldosterone antagonism
Postgrad. Med. J.,
March 1, 2010;
86(1013):
136 - 142.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Al Rashdan and H. Amin
Percutaneous Revascularization of Unprotected Left Main: Results of PCI Using Drug-eluting Stent in Ostial Versus Distal Bifurcation Disease
Angiology,
February 1, 2010;
61(1):
19 - 23.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
P. R. Kowey, P. Dorian, L. B. Mitchell, C. M. Pratt, D. Roy, P. J. Schwartz, J. Sadowski, D. Sobczyk, A. Bochenek, E. Toft, et al.
Vernakalant Hydrochloride for the Rapid Conversion of Atrial Fibrillation After Cardiac Surgery: A Randomized, Double-Blind, Placebo-Controlled Trial
Circ Arrhythm Electrophysiol,
December 1, 2009;
2(6):
652 - 659.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Sarraf, A. Masoumi, and R. W. Schrier
Cardiorenal Syndrome in Acute Decompensated Heart Failure
Clin. J. Am. Soc. Nephrol.,
December 1, 2009;
4(12):
2013 - 2026.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. M. Bradley, W. C. Levy, and D. L. Veenstra
Cost-Consequences of Ultrafiltration for Acute Heart Failure: A Decision Model Analysis
Circ Cardiovasc Qual Outcomes,
November 1, 2009;
2(6):
566 - 573.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. A. Bart
Treatment of Congestion in Congestive Heart Failure: Ultrafiltration Is the Only Rational Initial Treatment of Volume Overload in Decompensated Heart Failure
Circ Heart Fail,
September 1, 2009;
2(5):
499 - 504.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Bansal, J. Lindenfeld, and R. W. Schrier
Sodium Retention in Heart Failure and Cirrhosis: Potential Role of Natriuretic Doses of Mineralocorticoid Antagonist?
Circ Heart Fail,
July 1, 2009;
2(4):
370 - 376.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. F. Reed III, S. Eid, B. Edris, and A. D. Sumner
Prevalence of peripheral artery disease varies significantly depending upon the method of calculating ankle brachial index
European Journal of Cardiovascular Prevention & Rehabilitation,
June 1, 2009;
16(3):
377 - 381.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Tamburino, M. E. Di Salvo, D. Capodanno, A. Marzocchi, I. Sheiban, M. Margheri, A. Maresta, F. Barlocco, G. Sangiorgi, G. Piovaccari, et al.
Are drug-eluting stents superior to bare-metal stents in patients with unprotected non-bifurcational left main disease? Insights from a multicentre registry
Eur. Heart J.,
May 2, 2009;
30(10):
1171 - 1179.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Fogelgren, S. Yang, I. C. Sharp, O. J. Huckstep, W. Ma, S. J. Somponpun, E. C. Carlson, C. F. T. Uyehara, and S. Lozanoff
Deficiency in Six2 during prenatal development is associated with reduced nephron number, chronic renal failure, and hypertension in Br/+ adult mice
Am J Physiol Renal Physiol,
May 1, 2009;
296(5):
F1166 - F1178.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Damman, V. M. van Deursen, G. Navis, A. A. Voors, D. J. van Veldhuisen, and H. L. Hillege
Increased Central Venous Pressure Is Associated With Impaired Renal Function and Mortality in a Broad Spectrum of Patients With Cardiovascular Disease
J. Am. Coll. Cardiol.,
February 17, 2009;
53(7):
582 - 588.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Jessup and M. R. Costanzo
The Cardiorenal Syndrome: Do We Need a Change of Strategy or a Change of Tactics?
J. Am. Coll. Cardiol.,
February 17, 2009;
53(7):
597 - 599.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Pallares, E. R Powers, P. L Zwerner, A. Fowler, R. Reeves, and J. M Nappi
Barriers to Clopidogrel Adherence Following Placement of Drug-Eluting Stents
Ann. Pharmacother.,
February 1, 2009;
43(2):
259 - 267.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. T. La Rovere, G. D. Pinna, R. Maestri, E. Robbi, A. Caporotondi, G. Guazzotti, P. Sleight, and O. Febo
Prognostic Implications of Baroreflex Sensitivity in Heart Failure Patients in the Beta-Blocking Era
J. Am. Coll. Cardiol.,
January 13, 2009;
53(2):
193 - 199.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. H. Gray, M. S. Conte, M. D. Dake, M. R. Jaff, K. Kandarpa, S. R. Ramee, J. Rundback, R. Waksman, and for Writing Group 7
Atherosclerotic Peripheral Vascular Disease Symposium II: Lower-Extremity Revascularization: State of the Art
Circulation,
December 16, 2008;
118(25):
2864 - 2872.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. W. Schrier and S. Bansal
Pulmonary Hypertension, Right Ventricular Failure, and Kidney: Different from Left Ventricular Failure?
Clin. J. Am. Soc. Nephrol.,
September 1, 2008;
3(5):
1232 - 1237.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. W. Schrier
Blood Urea Nitrogen and Serum Creatinine: Not Married in Heart Failure
Circ Heart Fail,
May 1, 2008;
1(1):
2 - 5.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Klein, B. M. Massie, J. D. Leimberger, C. M. O'Connor, I. L. Pina, K. F. Adams Jr, R. M. Califf, M. Gheorghiade, and for the OPTIME-CHF Investigators
Admission or Changes in Renal Function During Hospitalization for Worsening Heart Failure Predict Postdischarge Survival: Results From the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF)
Circ Heart Fail,
May 1, 2008;
1(1):
25 - 33.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Kazory and E. A. Ross
Contemporary Trends in the Pharmacological and Extracorporeal Management of Heart Failure: A Nephrologic Perspective
Circulation,
February 19, 2008;
117(7):
975 - 983.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Ohno, S. Takamoto, and N. Motomura
Diabetic Retinopathy and Coronary Artery Disease From the Cardiac Surgeon's Perspective
Ann. Thorac. Surg.,
February 1, 2008;
85(2):
681 - 689.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Cotter, M. Metra, O. Milo-Cotter, H. C. Dittrich, and M. Gheorghiade
Fluid overload in acute heart failure -- Re-distribution and other mechanisms beyond fluid accumulation
Eur J Heart Fail,
February 1, 2008;
10(2):
165 - 169.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. J. Brugts, E. Boersma, M. Chonchol, J. W. Deckers, M. Bertrand, W. J. Remme, R. Ferrari, K. Fox, M. L. Simoons, and on behalf of the EUROPA Investigators
The Cardioprotective Effects of the Angiotensin-Converting Enzyme Inhibitor Perindopril in Patients With Stable Coronary Artery Disease Are Not Modified by Mild to Moderate Renal Insufficiency: Insights From the EUROPA Trial
J. Am. Coll. Cardiol.,
November 27, 2007;
50(22):
2148 - 2155.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. B. Chonchol, V. Aboyans, P. Lacroix, G. Smits, T. Berl, and M. Laskar
Long-term outcomes after coronary artery bypass grafting: Preoperative kidney function is prognostic
J. Thorac. Cardiovasc. Surg.,
September 1, 2007;
134(3):
683 - 689.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. R. Costanzo and on behalf of the UNLOAD Trial Investigators
Reply
J. Am. Coll. Cardiol.,
August 21, 2007;
50(8):
820 - 821.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L. Anderson, C. D. Adams, E. M. Antman, C. R. Bridges, R. M. Califf, D. E. Casey Jr, W. E. Chavey II, F. M. Fesmire, J. S. Hochman, T. N. Levin, et al.
ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction) Developed in Collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine
J. Am. Coll. Cardiol.,
August 6, 2007;
(2007)
j.jacc.2007.02.028v1.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. W. Schrier
Decreased Effective Blood Volume in Edematous Disorders: What Does This Mean?
J. Am. Soc. Nephrol.,
July 1, 2007;
18(7):
2028 - 2031.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. R. Costanzo, M. E. Guglin, M. T. Saltzberg, M. L. Jessup, B. A. Bart, J. R. Teerlink, B. E. Jaski, J. C. Fang, E. D. Feller, G. J. Haas, et al.
Ultrafiltration Versus Intravenous Diuretics for Patients Hospitalized for Acute Decompensated Heart Failure
J. Am. Coll. Cardiol.,
February 13, 2007;
49(6):
675 - 683.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. G. Wannamethee, A. G. Shaper, G. D.O. Lowe, L. Lennon, A. Rumley, and P. H. Whincup
Renal function and cardiovascular mortality in elderly men: the role of inflammatory, procoagulant, and endothelial biomarkers
Eur. Heart J.,
December 2, 2006;
27(24):
2975 - 2981.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Amann, C. Wanner, and E. Ritz
Cross-Talk between the Kidney and the Cardiovascular System
J. Am. Soc. Nephrol.,
August 1, 2006;
17(8):
2112 - 2119.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|